FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

November 20, 2020 -- The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials